# Pharmaco-epidemiological Study Describing a Population of Hypertensive Patients Treated With a Fixed-dose Combination of Telmisartan and Hydrochlorothiazide

> **NCT02248129** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 4255 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Telmisartan and hydrochlorothiazide

## Key facts

- **NCT ID:** NCT02248129
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2006-12
- **Final completion:** —
- **Target enrollment:** 4255 (ACTUAL)
- **Last updated:** 2014-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02248129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02248129, "Pharmaco-epidemiological Study Describing a Population of Hypertensive Patients Treated With a Fixed-dose Combination of Telmisartan and Hydrochlorothiazide". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02248129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*